73606-010Level 3
Empaveli (Pegcetacoplan)
**Product type:** Human Prescription Drug
**Active ingredient:** PEGCETACOPLAN
**Strength:** 1080 mg/20mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Apellis Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA215014)
**Pharmacologic class:** Complement Inhibitor [EPC], Complement Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/73606-010Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.